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SUMMARY
The recent release of the Obama Administration’s consultation 
document on the Implementation of the Global Health Initiative1, 
accompanied by the FY 2011 budget request 2, provide the 
most significant detail to date on this new initiative. First 
announced last year3,4, the Global Health Initiative (GHI) was 
proposed as a $63 billion, six-year (FY 2009–FY 2014) effort to 
develop a comprehensive U.S. global health strategy, building 
on disease specific initiatives to combat HIV, TB and malaria, as 
well as expanding to encompass broader global health targets, 
including maternal and child health (MCH), family planning 
and reproductive health (FP/RH), nutrition, and neglected 
tropical diseases (NTDs), and to strengthen underlying health 
systems (see Box 1). The GHI consultation document includes 
specific goals and targets, core principles, and an operational 
plan for implementing each targeted area (see Box 2). The FY 
2011 budget marks the half-way point in the Initiative’s funding 
and, if approved by Congress, would bring cumulative GHI 
funding to almost $27 billion, or 43%, of the proposed six-year 
total.5  The Administration has solicited public comment on 
the consultation document and several other next steps are expected, including the announcement of “GHI Plus” 
countries, a subset from among those receiving U.S. global health assistance to be selected for more intensified effort. 
Even as these developments continue to unfold, several significant and interrelated questions and issues remain 
on the table—rethinking a multi-pronged, multi-billion dollar investment that involves a myriad of global health 
challenges, programs, countries, and stakeholders, is an inherently complex undertaking, and one which is occurring 
against the backdrop of other broader assessments of U.S. foreign aid and development policy, as well as more 
general budgetary constraints. Given the complex environment, this policy brief highlights and summarizes some 
of the more pressing issues and questions on the GHI. They were identified based on review and analysis of recent 
reports in the field as well as public comments submitted in response to  the GHI consultation document.6,7,8,9,10,11,12,13 
BOX 1:  GHI Overview1,3,4
• Announced by President Obama on May 5, 2009
• $63 billion proposed over 6 years, FY 2009-2014
– $51 billion for PEPFAR (HIV, TB, Global Fund) & 
Malaria
– $12 billion for other global health priorities
• Integrated approach, government-wide strategy 
• Continued commitment to PEPFAR, slated to receive 
more than 70% of cumulative funding 
• Expanded focus to broader global health challenges, 
including maternal and child health, family planning/ 
reproductive health, neglected tropical diseases
• Emphasis on health system strengthening
• Emphasis on moving from process to outcomes, 
investing where significant returns can be achieved
• GHI budget includes:  HIV, TB, malaria, Global 
Fund, maternal and child health, nutrition, family 
planning/reproductive health, neglected tropical 
diseases, avian influenza and other public health 
threats
ApRIL 2010
Seven Core Principles  
1. Women- and girl-centered approach 
2. Strategic coordination and 
integration 
3. Strengthen and leverage key 
multilaterals and other partners
4. Country-ownership
5. Sustainability through health 
systems strengthening
6. Improve metrics, monitoring and 
evaluation 
7. Promote research and innovation
Four Main Implementation 
Components
1. Do more of what works, promote 
proven approaches
2. Build on and expand existing 
platforms 
3. Innovate for results
4. Collaborate for impact/promote 
country ownership 
Nine Target Areas
1. HIV/AIDS
2. Malaria
3. Tuberculosis
4. Maternal Health
5. Child Health
6. Nutrition
7. Family Planning/Reproductive Health
8. Neglected Tropical Diseases
9. Health Systems Strengthening
BOX 2:  GHI Core principles, Implementation Components, and Target Areas1 
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Eight distinct but interrelated issues were identified. These are briefly listed below, followed by a more detailed 
discussion that provides background and context on each as well as specific questions moving forward. 
1.  HOW WILL THE LEADERSHIp AND GOVERNANCE OF THE GHI BE STRUCTURED? 
How will coordination of the U.S. global health response be achieved across multiple agencies, programs, and 
Congressional committees? Is a new coordinating structure needed and if so, where is it best located—at the White 
House or within a federal agency? Are new Congressional authorities needed?
2.  HOW MUCH FUNDING WILL BE pROVIDED TO THE GHI AND HOW WILL FUNDING BE ALLOCATED WITHIN 
THE U.S. GLOBAL HEALTH pORTFOLIO?
Will the GHI reach $63 billion by FY 2014? Will further rebalancing of the portfolio occur and if so, how will funding 
be balanced between disease specific programs and broader, “horizontal” approaches? What criteria will be used to 
inform resource allocation decisions?
3. HOW CAN THE GHI’S TARGETS AND IMpACT BE MEASURED? 
What kinds of investments and structures are needed at the federal agency and country levels to foster greater 
monitoring and evaluation? How can new metrics and reporting requirements be implemented without increasing 
the burden on countries? What is the potential role, and limitations, of existing measurement tools? How can data 
gaps and limitations be overcome?
4. HOW CAN THE U.S. BEST pARTNER WITH RECIpIENT COUNTRIES TO pROMOTE “COUNTRY OWNERSHIp”? 
What is the appropriate balance between donor-defined and country-designed priorities? Is there a trade-off 
between country-ownership and accountability to donors? How will country-plans be developed with host country 
governments and other stakeholders, including civil society? 
5. HOW CAN U.S. ENGAGEMENT WITH OTHER INTERNATIONAL ACTORS, INCLUDING MULTILATERALS, 
DONOR GOVERNMENTS, AND THE pRIVATE SECTOR, FURTHER SUppORT COORDINATION, LEVERAGE 
RESOURCES AND MAXIMIZE SHARED IMpACT?
What should the funding balance be between multilateral and bilateral programs? To the extent that U.S. 
investments are channeled through multilateral organizations, how can concerns about accountability be 
addressed? Are there opportunities for further assessing or strengthening U.S. engagement in international health 
treaties, regulations, and other partnerships and agreements?
6. HOW WILL THE INCREASED EMpHASIS ON WOMEN AND GIRLS BE REALIZED IN U.S. GLOBAL HEALTH 
pROGRAMS?
How can a women- and girls-centered approach best be implemented at a country level? As country plans are 
developed or augmented, how can the importance of addressing women and girls be meaningfully incorporated? 
How can the U.S. reinforce and strengthen the global consensus that has emerged around the importance of 
addressing gender, women and girls?
7. HOW WILL THE U.S. DEFINE, IMpLEMENT, AND MEASURE HEALTH SYSTEMS STRENGTHENING?
What targets—either existing or newly developed—can be used to help assess U.S. investments in health systems? 
How can health systems investments be linked to health outcomes? As the U.S. moves to strengthen health 
systems, adopting a broader, “horizontal” approach to global health, what will be the implications for disease-
specific, vertical approaches? 
8. HOW WILL THE GHI BE COORDINATED WITH AND AFFECTED BY BROADER U.S. FOREIGN AID  
REFORM EFFORTS?
How will these different efforts affect the U.S. global health portfolio and the strategy outlined in the new GHI 
consultation document? What kinds of broader restructuring can be expected? Where can the U.S. global health 
response serve as a model for broader development reform efforts?
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BACKGROUND AND CONTEXT
1. HOW WILL THE LEADERSHIp AND GOVERNANCE OF THE GHI BE STRUCTURED? 
Background and Context:  
The U.S. government’s response to global health has grown significantly over time, and today, is a more than 
$10 billion annual effort, that includes the GHI as well as other U.S. programs and activities.5  This effort spans seven 
executive branch departments, numerous departmental operating units, several independent agencies, and more 
than 15 Congressional committees14 (see Figure 1). It encompasses multiple funding streams, programs, and initiatives, 
and operates in more than 80 countries. Yet historically, the U.S. global health architecture has had no formalized 
organizing mechanism or structure, having largely been built within separate agencies and around discrete “vertical”, 
or disease-specific, initiatives rather than “horizontal”, or more comprehensive, approaches that seek to address the 
multiple health challenges that often impact the same populations and communities simultaneously. Different U.S. 
agencies operate under different legislative authorities and mandates, have distinctive operating cultures, face unique 
and sometimes competing priorities, and control varying levels of funding for global health. For example, most global 
health funding is appropriated by Congress to foreign assistance agencies (the State Department and USAID), who 
in turn control the bulk of related programming; by contrast, little funding is provided directly to the Department of 
Health and Human Services (HHS), although its public health expertise is integral to carrying out the U.S. global health 
effort.5,14  Within the Congress, multiple authorizing and appropriating committees have jurisdiction over different 
pieces of the U.S. global health portfolio, and funding decisions have historically been tied to earmarks for specific 
diseases, conditions, or individual programs, rather than a more comprehensive approach.8,14 
This has resulted in a U.S. response that has been characterized as fragmented and stove-piped, inhibiting the 
opportunity to take advantage of synergies, be more strategic, maximize the U.S investment and, ultimately, do a 
better job in reaching the very populations who are the intended beneficiaries of U.S. global health assistance.6,7,8,9,10,12,15  
As such, a growing consensus has developed that better coordination is needed. Yet there is no clear path for doing  
so, and multiple recommendations have been promulgated over time. As early as 1997, the Institute of Medicine  
(IOM) called for the establishment of an interagency task force, recommending it be led by HHS given its scientific  
and technical expertise.16  More recently, the IOM reaffirmed its recommendation for a task force, but situated its 
leadership within the White House, to give it convening authority and the ability to make policy recommendations 
directly to the President.7 Other 
groups have also provided 
recommendations about 
leadership and structure.8,9,11,13   
A key issue raised by these 
organizations is the importance  
of Presidential leadership, which 
was central to the success of 
PEPFAR for example. 
The GHI itself was an attempt to 
create a coordinated strategy for 
U.S. global health programs, by 
developing a “comprehensive 
whole of government approach1” 
centered on the ultimate 
beneficiary of U.S. global health 
aid—the individual. Strategic 
coordination and integration 
is a core principle of the GHI, 
including “upstream integration” 
at the agency and program level, 
and “downstream integration”, at 
the point of contact or beneficiary 
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level. In terms of structure, the GHI was initially 
launched by the White House, under the auspices 
of the National Security Council (NSC) and 
the Office of Management and Budget (OMB), 
together with the State Department17, and each 
has continued to play an integral role. The White 
House also convened an interagency task force 
that began meeting last summer. More recently, a 
“trifecta” structure of the State Department, USAID, 
and HHS—the three main agencies with assets 
in U.S. global health—has been carrying forward 
implementation. To date, however, no formal or 
permanent coordinating structure for the GHI 
has been announced and several questions and 
options remain.
Key Issues:  
• How will coordination of the U.S. global health 
response be achieved across multiple agencies, 
programs, and Congressional committees? 
Is a new coordinating structure needed and if so, where is it best located—at the White House reporting to the 
President, within a single agency, or at multiple agencies? 
• Should there be a single designated “coordinator” for the GHI? 
• Are new Congressional authorities needed to carry out aspects of the GHI, such as funding authority across 
multiple funding streams or agencies, or to support new programming needs? 
• Can better coordination be achieved within Congress, including across Congressional committees and 
jurisdictions? 
TABLE 1:  GHI Funding and Budget Projections, FY 2009–FY 20145
$ in billions
FY 2009  
Enacted
FY 2010  
Enacted
FY 2011  
Budget
FY09-FY11  
Subtotal
FY09-FY14  
Proposed Total
FY09-FY11 
% of  
Proposed 
Total
FY12-FY14 
Amount 
Remaining$ % $ % $ % $ % $ %
PEPFAR (HIV, TB,  
Global Fund) $6.68 79% $6.84 77% $6.99 73% $20.50 76% >$44.1b* – – –
Malaria $0.55 6% $0.73 8% $0.83 9% $2.11 8% <$6.9b* – – –
PEPFAR & Malaria $7.23 86% $7.57 86% $7.82 82% $22.62 84% $51 81% 44% $28.38 
Other Global Health 
Priorities $1.19 14% $1.26 14% $1.75 18% $4.20 16% $12 19% 35% $7.80 
GLOBAL HEALTH 
INITIATIVE TOTAL $8.41 100% $8.83 100% $9.58 100% $26.81 100% $63 100% 43% $36.19 
*Estimate based on six-year GHI funding proposal. 
Note:  Amounts may not sum to totals due to rounding.
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FIGURE 2: U.S. Global Health Initiative (GHI),
Funding by Sector, FY 2009-FY 2011*
*FY 2011 is President’s Budget Request to Congress.
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2. HOW MUCH FUNDING WILL BE pROVIDED TO THE GHI AND HOW WILL FUNDING BE ALLOCATED WITHIN 
THE U.S. GLOBAL HEALTH pORTFOLIO?
Background and Context:  
International development assistance for global health provided by the U.S. and other donors has increased 
significantly in recent years,18,19 although it still falls short of need, according to recent estimates from The Taskforce on 
Innovative International Financing for Health Systems.20  Moreover, the recent economic crisis has likely exacerbated the 
needs of low- and middle-income countries at the very time that it has strained the budgets of donor governments 
and raised concerns about the ability to fill this gap in the future.20,21,22,23  As the largest donor of health assistance in 
the world, U.S. funding will play a critical role in this equation. 
While the GHI was proposed as a six-year, $63 billion initiative, it is not yet known what its overall funding level will 
be or how funding will be allocated within the U.S. global health portfolio. This is because all funding for U.S. global 
health programs is considered “discretionary spending”—that is, spending that must be appropriated by Congress 
each year (vs. “mandatory” or “direct” spending, such as for entitlement programs, that is determined by statutes 
other than appropriations acts and is generally automatically obligated each year). Not only are overall global health 
funding levels determined this way, but so is much of the funding allocated to individual global health programs or 
areas, historically through program or issue specific Congressional earmarks. Funding, therefore, is one of the most 
visible and explicit markers of policymaker priorities and often seen as a major policy lever in debates about U.S. 
global health policy and programming. When announcing the GHI, the Obama Administration indicated an intention 
to rebalance the global health portfolio, moving from what has largely been a disease specific approach to a broader, 
population-based one. This has raised questions about how such a shift would impact current disease programs, such 
as HIV treatment (where even keeping all those currently on treatment will require new resources in the future), as well 
as how the positive effects of vertical programs on broader health systems and capacity would be accounted for.9,24 ,25
With FY 2011 marking the half-way 
point in the GHI’s six-year budget, more 
information about these policy priorities 
is available, including whether the GHI is 
on track to reach $63 billion. The FY 2011 
request, if approved by Congress, would 
bring GHI funding to date to $26.8 billion, 
or 43% of the proposed six-year total. 
Funding over the remaining period 
(FY 2012–FY 2014) would need to total 
$36.2 billion (an average of $12 billion 
per year) to reach $63 billion, requiring a 
steeper rate of increase relative to the first 
three years of the GHI (see Table 1).5 
The $63 billion six-year GHI proposal 
included $51 billion for PEPFAR (HIV, TB, and 
the Global Fund) and malaria combined, 
and $12 billion for other global health 
priorities. If Congress approves the FY 2011 
budget request, funding for PEPFAR and 
malaria would reach 44% of this total and 
would need to more than double to reach $51 billion; funding for other global health priorities would be at 35% and 
would need to almost triple to reach its funding target (see Table 1).5  Congress provided another marker of funding 
priorities in the Tom lantos and Henry J. Hyde United States Global leadership Against HIV/AIDS, Tuberculosis, and 
Malaria Reauthorization Act of 2008 (lantos-Hyde) for the FY 2009–FY 2013 period; to reach the levels authorized  
by lantos-Hyde, funding for PEPFAR and malaria combined would need to more than double in the next two years 
(see Table 2).26 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011*
NTDs
T B
FP/RH
MCH/Nutrition
Malaria
GF
H I V
FIGURE 3: Distribution of Funding for Programs in the
U.S. Global Health Initiative (GHI), by Sector,
FY 2001-FY 2011*
*FY 2011 is President’s Budget Request to Congress.
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TABLE 2:  Funding for PEPFAR & Malaria Compared to Lantos-Hyde Reauthorization Levels, FY 2009 – FY 2013 5
$ in billions
FY 2009 
Enacted
FY 2010 
Enacted
FY 2011
Budget Req
FY09-FY11
Subtotal
Lantos-Hyde FY09-FY13 
Authorized Difference
PEPFAR:  HIV & Global Fund $6.50 $6.59 $6.74 $19.83 $39 $19.17
PEPFAR:  TB $0.18 $0.24 $0.25 $0.67 $4 $3.33
Malaria $0.55 $0.73 $0.83 $2.11 $5 $2.89
PEPFAR (HIV, TB, Global Fund)  
& MALARIA TOTAL $7.23 $7.57 $7.82 $22.62 $48 $25.38
Note:  Amounts may not sum to totals due to rounding.
looking further within the global health portfolio shows that some rebalancing has already begun to occur. Although 
HIV continues to make up the lion’s share of the GHI budget, its more recent increases have begun to slow, and 
funding for other global health priorities has risen at a faster rate. The fastest increases over the three-year period have 
been for NTDs, followed by MCH; MCH received the greatest amount of increase and therefore was the biggest driver 
of growth in the GHI’s budget (see Figure 3 and Table 3). These trends would need to continue if the GHI’s proposed 
six-year budget parameters are to be met. Yet it is not clear how best to make such resource allocation decisions 
moving forward. In addition, while the Administration has continued to request increased funding for global health, 
in contrast to a proposed freeze on all domestic discretionary spending2, and Congress has historically demonstrated 
strong bi-partisan support, it is not clear how current budgetary pressures will affect this calculus in the future. 
Key Issues:
• Will GHI funding reach $63 billion by FY 2014? Will lantos-Hyde funding levels be reached for HIV, TB, malaria and 
the Global Fund? How will budgetary pressures on the U.S. government affect funding?
• Should the U.S. global health funding portfolio be further rebalanced? If so, should rebalancing apply to existing or 
to future resources only? Can a “zero-sum” be avoided? Should there be a “hold harmless” approach? 
• What criteria should be used to make resource allocation decisions? Should a greater emphasis be placed on lower-cost 
interventions or on diseases that have received less attention in recent years? On diseases and conditions that currently 
exert the greatest burden or on those which have the potential to be eliminated? Should smaller benefits to a larger 
number take priority over larger benefits to a few? What is the right balance between targeting “low-hanging fruit” and 
the more difficult, but equally critical, challenges? What is the appropriate balance between prevention, care, and 
treatment? To what extent should the availability of other donor resources play a role in targeting U.S. investments? 
• How can these different criteria best be assessed to guide U.S. policymakers and program implementers? What is the 
appropriate role of cost effectiveness analysis? Can simulation modeling be used to inform resource allocation decisions? 
TABLE 3.  GHI Funding: Amount and Percent Change by Sector, FY 2009-FY 20115
$ in billions
FY 2009 
Enacted
FY 2010 
Enacted
FY 2011 
Budget Req
FY10-FY11  
($ and % change)
FY09-FY11  
($ and % change)
HIV/AIDS $5.50 $5.54 $5.74 $0.2 (4%) $0.24 (4%)
TB $0.18 $0.24 $0.25 $0.01 (3%) $0.07 (42%)
Malaria $0.55 $0.73 $0.83 $0.1 (14%) $0.29 (53%)
Global Fund $1.00 $1.05 $1.00 $-0.05 (-5%) $0 (0%)
MCH $0.44 $0.47 $0.70 $0.23 (48%) $0.26 (59%)
Nutrition $0.05 $0.08 $0.20 $0.13 (167%) $0.15 (264%)
FP/RH $0.46 $0.53 $0.59 $0.06 (12%) $0.14 (30%)
NTDs $0.03 $0.07 $0.16 $0.09 (138%) $0.13 (520%)
Other $0.21 $0.12 $0.11 $-0.01 (-11%) $-0.1 (-49%)
PEPFAR Subtotal $6.68 $6.84 $6.99 $0.15 (2%) $0.31 (5%)
PEPFAR & Malaria Subtotal $7.23 $7.57 $7.82 $0.25 (3%) $0.6 (8%)
Other Global Health Priorities Subtotal $1.19 $1.26 $1.75 $0.49 (39%) $0.57 (48%)
GLOBAL HEALTH INITIATIVE TOTAL $8.41 $8.83 $9.58 $0.75 (8%) $1.16 (14%)
Note: Amounts may not sum to totals due to rounding.
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3. HOW CAN THE GHI’S TARGETS AND IMpACT BE MEASURED? 
Background and Context:
Related closely to the issue of investment choices is that of measurement and assessing progress. A core principle of 
the GHI is to improve metrics and enhance monitoring and evaluation (M&E) of global health interventions, to move 
from process to outcomes, and be “results-oriented rather than expenditure- or input-based.”  An additional core 
principle is to promote research and innovation, including scaling-up operational and implementation research. The 
GHI includes specific targets in each of its major health areas over the life of the initiative, yet moving in this direction 
poses numerous challenges. These include both measurement challenges, as well as broader issues related to the 
GHI targets. Health is a complex domain, encompassing multiple dimensions, components, and levels making the 
measurement of investments particularly difficult. For example, while most would agree that measuring HIV incidence 
(new infections) is the best outcome measure for assessing HIV prevention interventions, it is one of the most difficult 
outcomes to measure and often cannot be measured directly (instead, proxy measures must sometimes be used) 
or within a time frame that matches donor budgeting cycles.27  There are also concerns about the limitations of 
existing measurement tools used to assess global health interventions, such as cost effectiveness analysis, which is a 
standard tool used to compare health interventions, but does not necessarily capture the benefits gained in one area 
due to a health intervention in another (e.g., impact of HIV treatment on maternal health24) or the benefits of health 
interventions on non-health measures (e.g., improved school attendance).28  In addition, U.S. investments intermingle 
with the investments of other donors and recipient countries, making it difficult to attribute outcomes directly to 
the U.S. or any other single funder. A further concern is the lack of data and information systems, particularly at the 
country level, for measuring impact. Finally, as the U.S. moves toward a more outcomes-based M&E framework, it will 
be important to consider and address not only the capacity of recipient countries in this area, but the potential to 
cause additional measurement burden on countries, many of which are already confronted by multiple and distinct 
reporting frameworks. 
Beyond these measurement challenges are considerations and questions about the GHI targets themselves, 
including their relationship to:  current global needs and burden; other global health targets, such as the Millennium 
Development Goals (MDGs),29 commitments made by the G830, and lantos-Hyde26; and actual GHI investments over 
time. Additionally, while the GHI approach is intended to be a broad and comprehensive one, promoting synergies 
and maximizing impact across interventions, the targets developed are specific to each health area; measuring 
interaction and integration will likely prove to be more difficult and there may be a need to develop new measures 
and measurement strategies in this area. 
There are several U.S. agencies already involved in global health operations research, including the National 
Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the U.S. Agency for International 
Development (USAID), although global health research activities have not always been coordinated across them. 
Moving forward, there may be additional opportunities to coordinate and build on their existing research networks 
and expertise in this area.
Key Issues:
• What kinds of investments and structures are needed at the federal agency and country levels to foster greater 
M&E? What will it cost to implement M&E? How much is enough or too much—would it be better to invest in 
health programs, or are the efficiency gains enough to offset M&E costs? 
• How can new metrics be implemented without increasing an already heavy and complex reporting burden on 
countries?
• How do the GHI targets track against current global health needs and burden, and compare to other global health 
targets and commitments, such as the MDGs?
• What is the potential role, and limitations, of existing measurement tools? How can data gaps and limitations be 
overcome? Where might proxy measures still be needed and how will their use be incorporated into an outcomes-
based system?
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4. HOW CAN THE U.S. BEST pARTNER WITH RECIpIENT COUNTRIES TO pROMOTE “COUNTRY-OWNERSHIp”? 
Background and Context:  
In recent years, there has been an increasing focus by the U.S. and other donors on the need to work with recipient 
countries differently, in partnership, to promote country-ownership. This is not only one of the core principles of the 
GHI, it has also been emphasized in several other, large-scale U.S. health and development initiatives, including the 
Millennium Challenge Corporation (MCC), created in 2004 as a new model for U.S. foreign assistance built on country 
“compacts” or partnerships31, and, more recently, in PEPFAR’s new five-year strategy32 and the Administration’s new 
Global Hunger and Food Security Initiative (GHFSI)33. The emphasis on country-ownership and partnership has been 
motivated by several factors, including a growing recognition that in order to move toward longer-term sustainability 
of programs, recipient country governments and other country stakeholders need to be integrally engaged in 
determining what is best for their needs and populations, designing and implementing programs, and building their 
health systems.34  In addition, there has been increased recognition that donor-funded programs at the country-level 
are often uncoordinated, fragmented, and duplicative, with multiple donors operating on similar issues and even 
individual donors operating multiple programs that may or may not be coordinated with one another.9  In many 
countries that receive U.S. global health and related development assistance, for example, there are six, seven, or even 
more distinct U.S. programs operating at the same time (see Figure 4).35  
The GHI approach, as stated in the 
consultation document, includes 
supporting partner countries in 
“managing, overseeing, and operating 
the functions of their national health 
systems” ensuring that “investments 
are aligned with national priorities” 
and supporting “partner government’s 
commitment and capacity so that 
investments are maintained in the 
future.”1  This is further described 
as investing in country-led plans, 
beginning with an assessment of 
existing plans as well as country health 
systems, financing gaps, and capacity 
to implement programs effectively. 
This approach will also designate a 
subset of countries, from among those 
receiving U.S. health assistance, as 
“GHI-Plus” countries, or countries that 
“provide significant opportunities for 
impact, evaluation, and partnership with governments.”1  GHI-Plus countries will be targeted with a more intensified 
effort, including additional funding ($200 million across GHI-Plus countries in FY 2011), and chosen based on several 
criteria, ranging from partner country interest in participation to the severity of health problems and challenges to be 
addressed. 
Moving ahead in this direction, however, will not be easy. First, country-ownership is not an easily defined or 
measured concept and there can be a tension, indeed a delicate balance, between donor defined and country 
determined priorities. This tension may also arise around the issue of donor accountability; that is, as more program 
ownership is vested in countries themselves, it may become more difficult to be accountable to donors. A further issue 
involves the need to change the way the U.S. government does business in countries, moving from what has become 
a heavy reliance on contracting with private (often U.S. based) entities to implement country-programs to working 
directly with host country governments. While both the Administration and Congress have stated their intention to 
shift in this direction, they have also acknowledged the challenges of doing so, including the need to bolster agency 
and field-level capacity in some cases.34,36,37,38,39,40
Major U.S. Government Global Health Programs
and Related Initiatives, 2010
1 or 2 Programs
3 or 4 Programs
5 or 6 Programs
7, 8, or 9 Programs
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Other areas to consider include the appropriate role of civil society (e.g., non-governmental organizations, community 
groups, indigenous groups, charitable organizations, faith-based organizations, etc.) in designing and implementing 
programs, particularly in countries where civil society has not been previously engaged; the implications of 
recipient government policies, such as those concerning the rights of women, in assessing partnership parameters; 
and the need to need ensure coordination not only among U.S. programs but with other donors to minimize the 
implementation and reporting burden on countries. Additionally, while a key goal of the GHI is to foster country 
ownership to enable countries to sustain programs over time, many of the countries facing the greatest health crises 
and challenges are those that have the least capacity or ability to sustain programs, and may require longer term 
U.S. investment to achieve such goals. Finally, while the GHI-Plus effort is designed to target a subset of countries to 
accelerate impact, it is not yet known whether the additional resources made available to them will be sufficient for 
this purpose. 
Key Issues:
• What is the appropriate balance between donor-defined and country-determined priorities? What is the trade-off 
between accountability to Congress and other policy-makers and country-ownership? 
• How will country-plans be developed with host country governments and other stakeholders? What should be the 
role of civil society in defining, determining, and owning programs? 
• What role should the U.S. play in using its investments to foster policy change?
• Will the additional effort provided to GHI-Plus countries be enough to show a differential impact?
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5. HOW CAN U.S. ENGAGEMENT WITH OTHER INTERNATIONAL ACTORS, INCLUDING MULTILATERALS, 
DONOR GOVERNMENTS, AND THE pRIVATE SECTOR, FURTHER SUppORT COORDINATION, LEVERAGE 
RESOURCES, AND MAXIMIZE SHARED IMpACT? 
Background and Context:  
The U.S. government’s engagement 
in global health has long involved 
working with international partners and 
organizations, including participation in 
the International Sanitary Conferences 
of the 19th Century, as well as helping 
to create the Pan American Health 
Organization (PAHO), the World 
Health Organization (WHO), and, more 
recently, the Global Fund to Fight AIDS, 
Tuberculosis and Malaria (the Global 
Fund).14  U.S. involvement in multilateral 
health organizations includes several 
different kinds of activities, ranging 
from signing onto international health 
treaties and agreements to organizational 
membership, governance, technical 
assistance, partnering, and funding. Some 
multilateral organizations themselves 
serve as financing vehicles to address 
global health challenges, such as 
the Global Fund and the Global Alliance for Vaccines and Immunisations (GAVI), and U.S. contributions to these 
organizations provide another avenue for the U.S. to expand its reach and impact; the U.S. is the largest donor to both 
the Global Fund41 and GAVI.42
Despite the U.S. government’s long standing and significant involvement in international organizations, the U.S. 
response to global health, as measured by funding and programs, has largely been bilateral—approximately 86% of 
U.S. funding for global health over the last decade has been channeled bilaterally5; this has continued with the GHI 54 
(see Figure 5). This is due to several factors including the significant field presence of U.S. programs and staff around 
the world, as well as a U.S. policy preference for targeting funding to certain countries and programs, allowing for U.S. 
defined priorities and accountability to Congress. As a result, some have called for increased multilateral engagement 
given the global nature of health challenges, the need to leverage U.S. investments with others and sustain programs 
over time, and concerns about the financial stability of international financing organizations such as the Global Fund. 
They have pointed to the emergence of new, innovative financing vehicles for global health, such as the International 
Financing Facility (IFF)43, Advance Market Commitment (AMC)44, and UNITAID,45 which may provide additional avenues 
for U.S. impact. However, such vehicles, as multiyear and contingent financial commitment mechanisms, have posed 
legal and administrative barriers to U.S. involvement.46  Others have highlighted potential opportunities for the U.S. 
to re-examine its engagement in international treaties and agreements. For example, while the U.S. is a party to many 
such agreements, others have yet to be ratified, such as the WHO Framework Convention on Tobacco Control  
(WHO FCTC)47,48 and the U.N. Convention on the Elimination of All Forms of Discrimination against Women (CEDAW).49 
Other international coalitions, such as the International Health Partnership (IHP+)9,50,  a partnership of donors and 
developing countries to better harmonize donor funding commitments and improve health systems, may also provide 
new opportunities for the U.S. (the U.S. is not currently one of the 13 donor government members of the IHP). Finally, 
there has been recent attention to the lack of a multilateral financing vehicle for MCH, prompting some to point to the 
need to assess whether an existing or new multilateral vehicle should be pursued for this purpose.71 The outcome of 
such a move could pose new options for the U.S. funding portfolio.
FIGURE 5: Distribution of Bilateral & Multilateral
Funding in the U.S. Global Health Initiative
(GHI), FY 2009 – FY 2011*
Bilateral
86%
Multilateral
14%
*FY 2011 is President’s Budget Request to Congress.
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Most recently, the Obama Administration has stated an intention to reinvigorate multilateral engagements and 
international partnerships on health and development generally and for the GHI specifically.1,51,52  In fact, a core 
principle of the GHI is strengthening and leveraging key multilateral organizations, global health partnerships, and 
private sector efforts, including commitment to achieving the Millennium Development Goals, and support for GAVI, 
the Global Fund, and other international partnerships and mechanisms. For example, Secretary Clinton recently  
stated support for ratifying CEDAW.53  
Key Issues:
• What is the appropriate funding balance between multilateral and bilateral programs?
• To the extent that U.S. investments are channeled through multilateral organizations, how can health impacts be 
attributed to the U.S. specifically? How can concerns about accountability be addressed? 
• Are there opportunities for further assessing or strengthening U.S. engagement in international health treaties, 
regulations, and other partnerships and agreements? Are there innovative financing mechanisms that can be 
further explored? 
• To what extent is the GHI’s success predicated on increased engagement with international partners?
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6. HOW WILL THE INCREASED EMpHASIS ON WOMEN AND GIRLS BE REALIZED IN U.S. GLOBAL HEALTH 
pROGRAMS?
Background and Context:  
There has been a growing recognition of the need to elevate a focus on women and girls in U.S. global health 
programs, particularly in the last decade. While U.S. programs have long funded interventions that address the health 
needs of women and girls, such as through MCH and FP/RH programs, as well as HIV, TB, and malaria, this approach 
has rarely targeted women and girls explicitly. Some of the programs that most directly affect women and girls, 
such as MCH and FP/RH, have received less funding historically and even seen decreases at times.5  The impetus for 
increased attention to women, girls, and gender more broadly has been twofold:  both the recognition that women 
and girls have had proportionately less access to global health programs and face greater disparities, along with the 
evidence that interventions that target the health of women and girls have high returns for the entire family unit. In 
fact, some have said that the global health response of the U.S. and others cannot be fully successful unless the health 
needs of women and girls are more explicitly addressed. 
In launching the GHI, as well as several other new U.S. efforts, including the creation a new office of Global Women’s 
Issues and the position of Ambassador-at-large for Global Women’s Issues at the State Department,55 the Obama 
Administration has further heightened attention and focus on women and girls. The Administration has also taken 
steps to enhance its international engagement in this area, including restoring funding for the United Nations 
Population Fund (UNFPA),56 and supporting calls for the creation of a new UN special agency for women.53  The first 
core principle of the GHI is to implement a women-and girls-centered approach and the consultation document 
discusses several general measures for doing so, including supporting systemic long term changes to remove barriers 
and increase access for women and girls, enhancing monitoring and evaluation of the health of women and girls, 
improving the training of health providers on gender issues, and involving women and girls in decision-making about 
program implementation. The GHI also includes several targets in MCH and FP/RH, areas that directly affect the health 
of women and girls. 
While there is widespread agreement on the importance of women and girls in global health programs, there 
are limited models on how to integrate such an approach at the agency or country level. There are also potential 
challenges that may arise if host countries have policies in place that may inhibit involvement and access of women 
and girls, and otherwise restrict their rights. In addition, there remain difficult political divisions in the U.S. and 
elsewhere around some key service areas that are important to addressing the health of women and girls, particularly 
family planning and access to safe abortion. Finally, there may be opportunities to further reinforce the global 
consensus that has emerged on women and girls with international partners, including the near term marker of the 
G8 Summit this June, at which the Canadian government is expected to champion a major new initiative on maternal, 
child, and newborn health, calling on donor governments to participate.57  In addition, although the U.S. has not yet 
ratified CEDAW, Secretary Clinton has indicated support for doing so.53 
Key Issues:
• How can a women and girls centered approach best be implemented at a country level? 
• As country plans are developed or augmented, how can the importance of addressing women and girls be 
meaningfully incorporated? Are incentives to do so needed and if so, what are appropriate incentives? What should 
the U.S. role be in countries that may have policies that are harmful to women and girls? 
• How comprehensively should services for women and girls be defined within the global health portfolio? Should 
non-health interventions that target women and girls, such as improved access to education, be accounted for?
• How can the U.S. reinforce and strengthen the global consensus that has emerged around the importance of 
addressing gender, women and girls, both to keep it on the agenda and to support other countries in their own 
efforts to do so?
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7. HOW WILL THE U.S. DEFINE, IMpLEMENT, AND MEASURE HEALTH SYSTEMS STRENGTHENING?
Background and Context:  
In recent years, the U.S. government, other donors and international organizations, and recipient countries have 
increasingly emphasized the necessity of strengthening health systems for reaching global health goals and 
improving the health status of those in low-and middle-income countries. At the launch of the GHI in May 2009, the 
President emphasized this goal, stating “…we will not be successful in our efforts to end deaths from AIDS, malaria, 
and tuberculosis unless we do more to improve health systems around the world…”.3  Similarly, stronger health 
systems are essential for the longer term U.S. foreign aid goal of shifting from an “emergency” response to one of 
sustainability—a core principle of the GHI is promoting sustainability through health systems strengthening (HSS). 
Finally, the U.S. has also noted that strengthening health systems in developing countries is important to U.S. self 
interest, particularly in the area of pandemic preparedness and prevention of health threats.
Although there is a consensus about the critical need to strengthen health systems for short and long term success of 
global health programs, it is one of the more difficult areas to define and operationalize. Connecting U.S. investments 
in health systems and capacity building to health outcomes is often more difficult to measure than other areas and 
agreed upon targets are not readily available, complicating efforts to demonstrate impact to U.S. policymakers, 
particularly those in Congress. The GHI targets for HSS, for example, are the only set for which measures have yet to be 
developed; rather, the U.S. has indicated that it will seek to develop measures working with other donors and partner 
countries. In addition, despite recognizing the importance of strengthening health systems, some have worried that a 
more horizontal approach could come at the expense of disease specific vertical approaches and not account for the 
role played by vertical programs in strengthening health systems.24  Finally, others have drawn attention to existing 
networks for addressing HSS, such as the IHP+, that the U.S. has not yet been directly involved in.9  
Despite these difficulties, there are several efforts underway to define and measure HSS that have or could further 
inform U.S. efforts. These include the WHO’s health systems framework which identifies six building blocks of health 
systems (service delivery; health workforce; information; medical products, vaccines and technologies; financing; 
and leadership and governance58) and associated measurement toolkits for countries,59 in addition to the work of the 
Global Fund60 and GAVI61, both of which fund and evaluate HSS projects, and the work of the IHP+.50  
Key Issues:
• What targets—either existing or newly developed—can be used to help assess U.S. investments in health systems? 
How can health systems investments be linked to health outcomes?
• What can be learned from other efforts, including those of the Global Fund and GAVI about design, 
implementation, and metrics for HSS projects?
• How will the U.S. balance the need to strengthen health systems, particularly in countries with the least 
infrastructure and capacity, with the need to also respond to more immediate health challenges? 
• As the U.S. moves to strengthen health systems, adopting a broader, “horizontal” approach to global health, what 
will be the implications for disease-specific vertical approaches? How can the role of disease-specific vertical 
approaches in strengthening health systems best be recognized, assessed, and accounted for?
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8. HOW WILL THE GHI BE COORDINATED WITH AND AFFECTED BY BROADER U.S. FOREIGN AID REFORM 
EFFORTS AND OTHER NEW INITIATIVES? 
Background and Context:  
In recent years, there has been increasing focus on the need to reform the U.S. foreign assistance framework and 
programs, including reauthorizing the Foreign Assistance Act of 1961, which created the statutory basis for U.S. 
foreign assistance, but has not been comprehensively amended since 1985.34,62,63,64  Calls for reform have gained 
momentum,37,38 particularly in the last year, and several broad reform efforts have either been introduced in the 
Congress or are already underway in the Administration. These include:  foreign aid reform legislation introduced in 
both the House39 and Senate40; a Presidential Study Directive (PSD) on Global Development, signed by the President 
in August 2009,65,66 that calls for a government-wide interagency review of global development policy; and the State 
Department’s Quadrennial Diplomacy and Development Review (QDDR) ,67 announced by Secretary Clinton in July 
2009, which introduced a new process for reviewing and developing blueprints for State and USAID diplomatic and 
development policy and structure. In addition to these reform efforts, the Administration recently launched a major 
new food security initiative, the Global Hunger and Food Security Initiative (GHFSI),33 which is still being developed, 
and has also signaled new attention to climate change efforts, including appointing a Special Envoy for Climate 
Change at the State Department.68 
The preliminary results of some of these efforts are expected very soon, and while none is health-focused, global 
health has regularly been cited by the Administration as a key example of its diplomacy and development efforts 
around the world and the GHFSI, GHI, and climate change issues have been talked about in tandem.69,70  Given that 
most global health funding and programs is located within foreign assistance agencies, what happens with these 
broader initiatives will almost undoubtedly affect the U.S. global health response. In addition, many of the core 
principles and objectives of the GHI are also being pursued through these other efforts, such as an enhanced focus 
on coordination and integration, country-ownership, and measurement and evaluation. At the same time, these 
initiatives are being developed or explored while the GHI itself is still in formation and as health programs and services 
continue to be delivered on the ground. Thus, it will be important to monitor their progress and status and assess their 
implications for the U.S. global health response.
Key Issues:
• How will these different efforts affect the U.S. global health portfolio and the strategy outlined in the new GHI 
consultation document? What kinds of broader restructuring of development can be expected? 
• Where can the U.S. global health response serve as a model for broader development reform efforts?
• Given the multiple reform efforts, assessments and initiatives, and uncertainty in their timing, how can the U.S. 
government best ensure coordination and synergies at the agency, program, and country-level, as well as with 
international partners?
• How can the global health community coordinate with other development stakeholders to best take advantage of 
new opportunities presented by reform efforts?
This policy brief was prepared by Jen Kates of the Kaiser Family Foundation. All figures in this brief, and others, can be 
downloaded from Kaiser Slides, http://facts.kff.org/results.aspx?view=slides&topic=76&start=1&num=4, located on the 
Foundation’s global health gateway, http://globalhealth.kff.org/. Kaiser slides are regularly updated with the most recent 
data available.
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